A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
BioNTech SE
DualityBio Inc.
Eli Lilly and Company
DualityBio Inc.
AstraZeneca
Ipsen
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ain Shams University